Abrocitinib versus Placebo or Dupilumab for Atopic Dermatitis von Bieber, Thomas, Simpson, Eric L, Silverberg, Jonathan I, Thaçi, Diamant, Paul, Carle, Pink, Andrew E, Kataoka, Yoko, Chu, Chia-Yu, DiBonaventura, Marco, Rojo, Ricardo, Antinew, Jeremias, Ionita, Ileana, Sinclair, Rodney, Forman, Seth, Zdybski, Jacek, Biswas, Pinaki, Malhotra, Bimal, Zhang, Fan, Valdez, Hernan

Volltext

Integrated Safety Analysis of Abrocitinib for the Treatment of Moderate-to-Severe Atopic Dermatitis From the Phase II and Phase III Clinical Trial Program von Simpson, Eric L., Silverberg, Jonathan I., Nosbaum, Audrey, Winthrop, Kevin L., Guttman-Yassky, Emma, Hoffmeister, Karin M., Egeberg, Alexander, Valdez, Hernan, Zhang, Min, Farooqui, Saleem A., Romero, William, Thorpe, Andrew J., Rojo, Ricardo, Johnson, Susan

Volltext

Efficacy and Safety of Azithromycin-Chloroquine versus Sulfadoxine-Pyrimethamine for Intermittent Preventive Treatment of Plasmodium falciparum Malaria Infection in Pregnant Women... von Kimani, Joshua, Phiri, Kamija, Kamiza, Steve, Duparc, Stephan, Ayoub, Ayman, Rojo, Ricardo, Robbins, Jeffery, Orrico, Russell, Vandenbroucke, Pol

Volltext

Efficacy and safety of abrocitinib monotherapy in adolescents and adults: a post hoc analysis of the phase 3 JAK1 atopic dermatitis efficacy and safety (JADE) REGIMEN clinical tria... von Flohr, Carsten, Cork, Michael J., Ardern-Jones, Michael R., Eichenfield, Lawrence F., Barbarot, Sébastien, Feeney, Claire, Rojo, Ricardo, Lazariciu, Irina, Nesnas, John

Volltext

COVID-19: age, Interleukin-6, C-reactive protein, and lymphocytes as key clues from a multicentre retrospective study von Jurado, Aurora, Martin, Maria C., Abad-Molina, Cristina, Orduna, Antonio, Martinez, Alba, Ocana, Esther, Yarce, Oscar, Navas, Ana M., Trujillo, Antonio, Fernandez, Luis, Vergara, Esther, Rodriguez, Beatriz, Quirant, Bibiana, Martinez-Caceres, Eva, Hernandez, Manuel, Perurena-Prieto, Janire, Gil, Juana, Cantenys, Sergi, Gonzalez-Martinez, Gema, Martinez-Saavedra, Maria T., Rojo, Ricardo, Marco, Francisco M., Mora, Sergio, Ontanon, Jesus, Lopez-Hoyos, Marcos, Ocejo-Vinyals, Gonzalo, Melero, Josefa, Aguilar, Marta, Almeida, Delia, Medina, Silvia, Vegas, Maria C., Jimenez, Yesenia, Prada, Alvaro, Monzon, David, Boix, Francisco, Cunill, Vanesa, Molina, Juan

Volltext

Parasitological Clearance Rates and Drug Concentrations of a Fixed Dose Combination of Azithromycin-Chloroquine in Asymptomatic Pregnant Women with Plasmodium Falciparum Parasitemi... von Phiri, Kamija, Kimani, Joshua, Mtove, George A, Zhao, Qinying, Rojo, Ricardo, Robbins, Jeffery, Duparc, Stephan, Ayoub, Ayman, Vandenbroucke, Pol

Volltext

Multiple-level stakeholder engagement in malaria clinical trials: addressing the challenges of conducting clinical research in resource-limited settings von Mtove, George, Kimani, Joshua, Kisinza, William, Makenga, Geofrey, Mangesho, Peter, Duparc, Stephan, Nakalembe, Miriam, Phiri, Kamija S, Orrico, Russell, Rojo, Ricardo, Vandenbroucke, Pol

Volltext

Fosdagrocorat (PF-04171327) versus prednisone or placebo in rheumatoid arthritis: a randomised, double-blind, multicentre, phase IIb study von Buttgereit, Frank, Strand, Vibeke, Lee, Eun Bong, Simon-Campos, Abraham, McCabe, Dorothy, Genet, Astrid, Tammara, Brinda, Rojo, Ricardo, Hey-Hadavi, Judith

Volltext

Economic impact of abrocitinib monotherapy and combination therapy in patients with moderate-to-severe atopic dermatitis: Results from JADE MONO-2 and JADE COMPARE von Gooderham, Melinda J., Chu, Chia-Yu, Rojo, Ricardo, Valdez, Hernan, Biswas, Pinaki, Cameron, Michael C., Feeney, Claire, Encinas, Gerardo A., Peeples-Lamirande, Kathleen, Cappelleri, Joseph C., Myers, Daniela E., DiBonaventura, Marco

Volltext

Efficacy and Safety of Abrocitinib in Patients With Moderate-to-Severe Atopic Dermatitis: A Randomized Clinical Trial von Silverberg, Jonathan I, Simpson, Eric L, Thyssen, Jacob P, Gooderham, Melinda, Chan, Gary, Feeney, Claire, Biswas, Pinaki, Valdez, Hernan, DiBonaventura, Marco, Nduaka, Chudy, Rojo, Ricardo

Volltext

Efficacy and safety of abrocitinib in adults and adolescents with moderate-to-severe atopic dermatitis (JADE MONO-1): a multicentre, double-blind, randomised, placebo-controlled, p... von Simpson, Eric L, Sinclair, Rodney, Forman, Seth, Wollenberg, Andreas, Aschoff, Roland, Cork, Michael, Bieber, Thomas, Thyssen, Jacob P, Yosipovitch, Gil, Flohr, Carsten, Magnolo, Nina, Maari, Catherine, Feeney, Claire, Biswas, Pinaki, Tatulych, Svitlana, Valdez, Hernan, Rojo, Ricardo

Volltext

Nipocalimab, an anti-FcRn monoclonal antibody, in participants with moderate to severe active rheumatoid arthritis and inadequate response or intolerance to anti-TNF therapy: resul... von Taylor, Peter C, Schett, Georg, Huizinga, Tom WJ, Wang, Qingmin, Ibrahim, Fowzia, Zhou, Bei, Liva, Sophia G, Shaik, Jafar Sadik B, Xiong, Yuan, Leu, Jocelyn H, Panchakshari, Rohit A, Loza, Matthew J, Ma, Keying, Dhatt, Harman, Rojo Cella, Ricardo, Karyekar, Chetan S, Cuff, Carolyn A, Gao, Sheng, Fei, Kaiyin

Volltext

Alveolar Proteinosis: The Role of Anti-GM-CSF Antibodies von Villar, Ana, Rojo, Ricardo

Volltext

Efficacy and Safety of Abrocitinib in Combination With Topical Therapy in Adolescents With Moderate-to-Severe Atopic Dermatitis: The JADE TEEN Randomized Clinical Trial von Eichenfield, Lawrence F, Flohr, Carsten, Sidbury, Robert, Siegfried, Elaine, Szalai, Zsuzsanna, Galus, Ryszard, Yao, Zhirong, Takahashi, Hidetoshi, Barbarot, Sébastien, Feeney, Claire, Zhang, Fan, DiBonaventura, Marco, Rojo, Ricardo, Valdez, Hernan, Chan, Gary

Volltext

Efficacy and safety of abrocitinib versus dupilumab in adults with moderate-to-severe atopic dermatitis: a randomised, double-blind, multicentre phase 3 trial von Reich, Kristian, Thyssen, Jacob P, Blauvelt, Andrew, Eyerich, Kilian, Soong, Weily, Rice, Zakiya P, Hong, H Chih-ho, Katoh, Norito, Valenzuela, Fernando, DiBonaventura, Marco, Bratt, Tamara A, Zhang, Fan, Clibborn, Claire, Rojo, Ricardo, Valdez, Hernan, Kerkmann, Urs

Volltext

Abrocitinib induction, randomized withdrawal, and retreatment in patients with moderate-to-severe atopic dermatitis: Results from the JAK1 Atopic Dermatitis Efficacy and Safety (JA... von Blauvelt, Andrew, Silverberg, Jonathan I., Lynde, Charles W., Bieber, Thomas, Eisman, Samantha, Zdybski, Jacek, Gubelin, Walter, Simpson, Eric L., Valenzuela, Fernando, Criado, Paulo Ricardo, Lebwohl, Mark G., Feeney, Claire, Khan, Tahira, Biswas, Pinaki, DiBonaventura, Marco, Valdez, Hernan, Cameron, Michael C., Rojo, Ricardo

Volltext

Abrocitinib for atopic dermatitis reply von Simpson, Eric L., Bieber, Thomas, Thyssen, Jacob P., Valdez, Hernan, Rojo, Ricardo

Volltext

Corrigendum to “Recommendations for the use of anti-dsDNA autoantibodies in the diagnosis and follow-up of systemic lupus erythematosus – A proposal from an expert panel” [Autoimmu... von Rojo, Ricardo, Calvo Alén, Jaime, Prada, Álvaro, Valor, Santiago, Roy, Garbiñe, López-Hoyos, Marcos, Cervera, Ricard, Mateos, Paloma Sánchez, Roger, Aurora Jurado

Volltext

Abrocitinib for atopic dermatitis – Authors' reply von Simpson, Eric L, Bieber, Thomas, Thyssen, Jacob P, Valdez, Hernan, Rojo, Ricardo

Volltext

Patient-Reported Outcomes (PROs) With Abrocitinib Treatment in Adolescent Patients With Moderate-to-Severe Atopic Dermatitis (AD): Results From the Phase 3 JADE TEEN Study von McMichael, Amy, Cork, Michael, Teng, Joyce, Rojo, Ricardo, Valdez, Hernan, Zhang, Fan, Myers, Daniela, Chan, Gary, DiBonaventura, Marco

Volltext